Critical Limb Ischemia: Current Trends and Future Directions.
作者信息
Teraa Martin, Conte Michael S, Moll Frans L, Verhaar Marianne C
机构信息
Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands
Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA.
出版信息
J Am Heart Assoc. 2016 Feb 23;5(2):e002938. doi: 10.1161/JAHA.115.002938.
Abstract
摘要
相似文献
1
Critical Limb Ischemia: Current Trends and Future Directions.严重肢体缺血：当前趋势与未来方向
J Am Heart Assoc. 2016 Feb 23;5(2):e002938. doi: 10.1161/JAHA.115.002938.
2
Advances in the Treatment of Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血的治疗进展
J Endovasc Ther. 2020 Aug;27(4):521-523. doi: 10.1177/1526602820942857.
3
Evolution of Major Amputation Risk in Patients Hospitalized in France for Critical Limb Ischemia: The COPART Registry.法国因严重肢体缺血住院患者的主要截肢风险演变：COPART 登记研究。
Angiology. 2021 Apr;72(4):315-321. doi: 10.1177/0003319720976823. Epub 2020 Dec 3.
4
Peripheral artery disease: breakthroughs in techniques and treatments.外周动脉疾病：技术与治疗的突破
J Cardiovasc Surg (Torino). 2017 Oct;58(5):689. doi: 10.23736/S0021-9509.17.10024-8.
5
Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia.预测模型死亡率包括伤口、缺血、足部感染分类在患者进行血运重建的临界肢体缺血。
Circ Cardiovasc Interv. 2019 Dec;12(12):e008015. doi: 10.1161/CIRCINTERVENTIONS.119.008015. Epub 2019 Nov 27.
6
Surgical and endovascular venous arterialization: ready to take the "desert" by storm?手术及血管内静脉动脉化：准备好席卷“荒漠”了吗？
J Cardiovasc Surg (Torino). 2017 Jun;58(3):402-408. doi: 10.23736/S0021-9509.17.09844-5. Epub 2017 Feb 2.
7
Key Concepts in Critical Limb Ischemia: Selected Proceedings from the 2015 Vascular Interventional Advances Meeting.严重肢体缺血的关键概念：2015年血管介入进展会议论文选集
Ann Vasc Surg. 2017 Jan;38:191-205. doi: 10.1016/j.avsg.2016.08.001. Epub 2016 Aug 26.
8
Retrograde pedal access for patients with critical limb ischemia.逆行足背动脉入路在严重肢体缺血患者中的应用。
J Vasc Surg. 2014 Aug;60(2):375-81. doi: 10.1016/j.jvs.2014.02.038. Epub 2014 Mar 18.
9
Impact of Nutritional State on Critical Limb Ischemia Early Outcomes (DENUCRITICC Study).营养状态对严重肢体缺血早期结局的影响（DENUCRITICC研究）
Ann Vasc Surg. 2017 Nov;45:10-15. doi: 10.1016/j.avsg.2017.04.030. Epub 2017 May 8.
10
The frontline in the battle to eliminate major amputation from the landscape of treatment for CLI.在消除CLI治疗领域中主要截肢这一现象的战斗中的前沿阵地。
J Cardiovasc Surg (Torino). 2017 Jun;58(3):369-370. doi: 10.23736/S0021-9509.17.09910-4.
引用本文的文献
1
O-GlcNAcylation promotes angiogenic transdifferentiation to reverse vascular ischemia.O-连接的N-乙酰葡糖胺化促进血管生成转分化以逆转血管缺血。
Nat Cardiovasc Res. 2025 Jul 4. doi: 10.1038/s44161-025-00673-7.
2
Limb Salvage in Patients with Concomitant Advanced Malignancy.合并晚期恶性肿瘤患者的肢体挽救
J Clin Med. 2025 Feb 28;14(5):1642. doi: 10.3390/jcm14051642.
3
ROS-scavenging ultrasonicated graphene oxide/alginate microgels for mesenchymal stem cell delivery and hindlimb ischemia treatment.用于间充质干细胞递送和后肢缺血治疗的活性氧清除超声氧化石墨烯/藻酸盐微凝胶
Mater Today Bio. 2024 Oct 10;29:101289. doi: 10.1016/j.mtbio.2024.101289. eCollection 2024 Dec.
4
Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia.血管重建的新兴策略：细胞衍生的细胞外囊泡和人工纳米囊泡在严重肢体缺血中的应用
Bioengineering (Basel). 2025 Jan 20;12(1):92. doi: 10.3390/bioengineering12010092.
5
Cellular therapy for the peripheral arterial disease treatment: Protocol for a systematic review and meta-analysis.用于外周动脉疾病治疗的细胞疗法：系统评价与荟萃分析方案
PLoS One. 2025 Jan 9;20(1):e0314070. doi: 10.1371/journal.pone.0314070. eCollection 2025.
6
Availability of the Great Saphenous Veins as Conduits for Arterial Bypass Surgery in Patients with Varicose Veins.大隐静脉作为静脉曲张患者动脉搭桥手术血管通道的可用性
J Clin Med. 2024 Dec 18;13(24):7747. doi: 10.3390/jcm13247747.
7
Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study.脊髓刺激对患有慢性肢体威胁性缺血的糖尿病患者的有效性：小型队列研究。
Front Surg. 2024 Dec 9;11:1451622. doi: 10.3389/fsurg.2024.1451622. eCollection 2024.
8
Autologous cell therapy for ischemic diabetic foot: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome.缺血性糖尿病足的自体细胞治疗：一项关于制定意大利糖尿病足综合征治疗指南的随机对照试验的荟萃分析。
Acta Diabetol. 2024 Nov 15. doi: 10.1007/s00592-024-02393-z.
9
Contrast-Enhanced Ultrasound of Mouse Models of Hindlimb Ischemia Reveals Persistent Perfusion Deficits and Distinctive Muscle Perfusion Patterns.对比增强超声在小鼠后肢缺血模型中的应用揭示了持续的灌注缺陷和独特的肌肉灌注模式。
Ultrasound Med Biol. 2025 Jan;51(1):26-32. doi: 10.1016/j.ultrasmedbio.2024.08.013. Epub 2024 Oct 18.
10
The Systemic Effect of Ischemia Training and Its Impact on Bone Marrow-Derived Monocytes.缺血训练的系统效应及其对骨髓来源单核细胞的影响。
Cells. 2024 Sep 24;13(19):1602. doi: 10.3390/cells13191602.
本文引用的文献
1
Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.骨髓源性细胞疗法治疗严重肢体缺血：随机安慰剂对照试验的荟萃分析
Eur J Vasc Endovasc Surg. 2015 Dec;50(6):775-83. doi: 10.1016/j.ejvs.2015.08.018. Epub 2015 Oct 12.
2
The natural history of untreated severe or critical limb ischemia.未经治疗的严重或危急肢体缺血的自然病程。
J Vasc Surg. 2015 Dec;62(6):1642-51.e3. doi: 10.1016/j.jvs.2015.07.065. Epub 2015 Sep 26.
3
Bypass surgery versus endovascular interventions in severe or critical limb ischemia.严重或危急肢体缺血的搭桥手术与血管内介入治疗对比
J Vasc Surg. 2016 Jan;63(1):244-53.e11. doi: 10.1016/j.jvs.2015.07.068. Epub 2015 Sep 11.
4
Therapeutic angiogenesis for critical limb ischemia.用于严重肢体缺血的治疗性血管生成
Semin Vasc Surg. 2014 Mar;27(1):23-31. doi: 10.1053/j.semvascsurg.2014.10.001. Epub 2014 Oct 17.
5
The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing.血管外科学会基于伤口、缺血和足部感染（WIfI）的下肢肢体威胁分类系统与大截肢风险和伤口愈合时间相关。
J Vasc Surg. 2015 Apr;61(4):939-44. doi: 10.1016/j.jvs.2014.11.045. Epub 2015 Feb 2.
6
Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial.无法手术肢体缺血患者重复动脉内输注骨髓单核细胞的效果：随机、双盲、安慰剂对照的经皮动脉内补充（ Juventas ）试验中再生内皮祖细胞。
Circulation. 2015 Mar 10;131(10):851-60. doi: 10.1161/CIRCULATIONAHA.114.012913. Epub 2015 Jan 7.
7
The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia.最佳下肢临界缺血试验（BEST-CLI）：一项评估哪种治疗方法最适合下肢临界缺血患者的多学科研究。
Tech Vasc Interv Radiol. 2014 Sep;17(3):221-4. doi: 10.1053/j.tvir.2014.08.012.
8
Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.严重肢体缺血患者间充质基质细胞的血管生成能力与健康对照相当。
Mol Ther. 2014 Nov;22(11):1960-70. doi: 10.1038/mt.2014.161. Epub 2014 Sep 1.
9
Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia.多学科护理可提高慢性肢体严重缺血患者的保肢生存率。
J Vasc Surg. 2015 Jan;61(1):162-9. doi: 10.1016/j.jvs.2014.05.101. Epub 2014 Jul 26.
10
Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia.定义严重肢体缺血下肢搭桥术后的风险并预测不良事件
Vasc Health Risk Manag. 2014 Jun 23;10:367-74. doi: 10.2147/VHRM.S54350. eCollection 2014.
Zotero 插件